Dsg1 |
Knockout |
Perinatal Lethal |
epidermal water loss, severe blistering |
[124] |
Dsg2 |
Knockout |
Embryonic Lethal |
Pre-implantation lethality, potentially non-desmosomal role |
[125] |
Suprabasal Epidermal Misexpression |
Not Lethal |
Hyperproliferation, abnormal differentiation, barrier defects |
[28] |
Dsg3 |
Knockout |
Not Lethal |
Separated keratinocytes, weakened desmosomal adhesion in oral mucosa |
[126] |
Suprabasal Epidermal Misexpression |
Not Lethal |
Hyperproliferation, abnormal differentiation, barrier defects |
[127] |
Dsc1 |
Knockout |
Not Lethal |
Epidermal hyperproliferation, loss of cell-cell adhesion |
[128] |
Dsc3 |
Knockout |
Embryonic Lethal |
Post-implantation lethality, potentially non-desmosomal role |
[129] |
Epidermal Conditional |
Not Lethal |
Epidermal fragility, hair loss |
[130] |
Suprabasal Epidermal Misexpression |
Not Lethal |
Hyperproliferation, abnormal differentiation, barrier defects |
[123] |
PG |
Knockout |
Embryonic Lethal |
Heart defects, skin fragility |
[131] |
Pkp1 |
Knockout |
Postnatal Lethality |
Epidermal fragility, tight junction defects, growth defects |
[132] |
DP |
Knockout |
Embryonic Lethal |
Die at E6.5 |
[133] |
Epidermal Conditional |
Perinatal Lethal |
Severe skin fragility, disrupted barrier function |
[134] |